Chang S Y, Weber E J, Ness Kp Van, Eaton D L, Kelly E J
Department of Occupational and Environmental Health Sciences, University of Washington, Seattle, Washington, USA.
Department of Pharmaceutics, University of Washington, Seattle, Washington, USA.
Clin Pharmacol Ther. 2016 Nov;100(5):464-478. doi: 10.1002/cpt.436. Epub 2016 Aug 27.
Because of complex cellular microenvironments of both the liver and kidneys, accurate modeling of transport function has remained a challenge, leaving a dire need for models that can faithfully recapitulate both the architecture and cell-cell interactions observed in vivo. The study of hepatic and renal transport function is a fundamental component of understanding the metabolic fate of drugs and xenobiotics; however, there are few in vitro systems conducive for these types of studies. For both the hepatic and renal systems, we provide an overview of the location and function of the most significant phase I/II/III (transporter) of enzymes, and then review current in vitro systems for the suitability of a transporter function study and provide details on microphysiological systems that lead the field in these investigations. Microphysiological modeling of the liver and kidneys using "organ-on-a-chip" technologies is rapidly advancing in transport function assessment and has emerged as a promising method to evaluate drug and xenobiotic metabolism. Future directions for the field are also discussed along with technical challenges encountered in complex multiple-organs-on-chips development.
由于肝脏和肾脏具有复杂的细胞微环境,准确模拟转运功能仍然是一项挑战,迫切需要能够忠实地重现体内观察到的结构和细胞间相互作用的模型。肝和肾转运功能的研究是理解药物和异源生物代谢命运的基本组成部分;然而,有利于这类研究的体外系统很少。对于肝和肾系统,我们概述了最重要的I/II/III期(转运体)酶的位置和功能,然后回顾当前用于转运体功能研究适用性的体外系统,并详细介绍在这些研究中处于领先地位的微生理系统。使用“芯片上器官”技术对肝脏和肾脏进行微生理建模在转运功能评估方面正在迅速发展,并已成为评估药物和异源生物代谢的一种有前景的方法。还讨论了该领域的未来方向以及在复杂的多器官芯片开发中遇到的技术挑战。